Healthcare provider profile · identity verified

Angela Mae Riddle, APRN

Nurse Practitioner · BEAUFORT, SC · NPI 1104121730

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Potassium Chloride	Potassium Chloride	446	33
Eliquis	Apixaban	284	24
Omeprazole	Omeprazole	242	48
Levothyroxine Sodium	Levothyroxine Sodium	226	29
Amlodipine Besylate	Amlodipine Besylate	208	30
Escitalopram Oxalate	Escitalopram Oxalate	183	15
Atorvastatin Calcium	Atorvastatin Calcium	161	30
Gabapentin	Gabapentin	155	25
Buspirone Hcl	Buspirone Hcl	143	15
Furosemide	Furosemide	140	22
Metoprolol Tartrate	Metoprolol Tartrate	127	15
Pantoprazole Sodium	Pantoprazole Sodium	108	21
Lisinopril	Lisinopril	104	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	98	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	95	14
Xarelto	Rivaroxaban	93	11
Trazodone Hcl	Trazodone Hcl	92	12
Metoprolol Succinate	Metoprolol Succinate	90	17
Mirtazapine	Mirtazapine	88	15
Movantik	Naloxegol Oxalate	80	suppressed
Warfarin Sodium	Warfarin Sodium	75	suppressed
Famotidine	Famotidine	72	suppressed
Januvia	Sitagliptin Phosphate	68	suppressed
Sucralfate	Sucralfate	67	suppressed
Prednisone	Prednisone	63	11
Amiodarone Hcl	Amiodarone Hcl	62	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	62	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	suppressed
Humalog Kwikpen U-100	Insulin Lispro	59	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	58	12
Carvedilol	Carvedilol	57	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	57	suppressed
Rivastigmine	Rivastigmine Tartrate	57	suppressed
Sertraline Hcl	Sertraline Hcl	57	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	suppressed
Clopidogrel	Clopidogrel Bisulfate	55	15
Tramadol Hcl	Tramadol Hcl	53	18
Ondansetron Hcl	Ondansetron Hcl	51	13
Donepezil Hcl	Donepezil Hcl	50	suppressed
Montelukast Sodium	Montelukast Sodium	50	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	45	suppressed
Allopurinol	Allopurinol	44	suppressed
Hydralazine Hcl	Hydralazine Hcl	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	41	suppressed
Valsartan	Valsartan	41	suppressed
Losartan Potassium	Losartan Potassium	40	11
Bupropion Hcl	Bupropion Hcl	36	suppressed
Scopolamine	Scopolamine	35	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	33	18
Nifedipine Er	Nifedipine	33	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Divalproex Sodium	Divalproex Sodium	32	suppressed
Metformin Hcl	Metformin Hcl	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Glipizide Er	Glipizide	30	suppressed
Levetiracetam	Levetiracetam	30	suppressed
Metformin Hcl Er	Metformin Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	27	suppressed
Mupirocin	Mupirocin	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Methimazole	Methimazole	22	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	22	suppressed
Torsemide	Torsemide	22	suppressed
Baclofen	Baclofen	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Creon	Lipase/Protease/Amylase	21	suppressed
Diltiazem Hcl	Diltiazem Hcl	20	suppressed
Glipizide	Glipizide	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Nystatin	Nystatin	20	13
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Timolol Maleate	Timolol Maleate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Finasteride	Finasteride	18	suppressed
Indapamide	Indapamide	18	suppressed
Nyamyc	Nystatin	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	14
Metolazone	Metolazone	17	suppressed
Moxifloxacin	Moxifloxacin Hcl	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Calcitriol	Calcitriol	15	suppressed
Cefdinir	Cefdinir	15	11
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Zaleplon	Zaleplon	15	suppressed
Lorazepam	Lorazepam	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Digoxin	Digoxin	13	suppressed
Risperidone	Risperidone	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Diazepam	Diazepam	11	suppressed
Gemtesa	Vibegron	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nystop	Nystatin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error